Detalles de la búsqueda
1.
Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity.
Arch Toxicol
; 97(8): 2209-2217, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221426
2.
Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy.
Toxicol Appl Pharmacol
; 434: 115797, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780725
3.
S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein.
Pharm Res
; 37(3): 58, 2020 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32086630
4.
Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics.
Drug Metab Dispos
; 47(9): 954-960, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31266750
5.
Interactions of Alectinib with Human ATP-Binding Cassette Drug Efflux Transporters and Cytochrome P450 Biotransformation Enzymes: Effect on Pharmacokinetic Multidrug Resistance.
Drug Metab Dispos
; 47(7): 699-709, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068367
6.
Brivanib Exhibits Potential for Pharmacokinetic Drug-Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes.
Mol Pharm
; 16(11): 4436-4450, 2019 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31633365
7.
Carltonine-derived compounds for targeted butyrylcholinesterase inhibition.
RSC Med Chem
; 15(5): 1601-1625, 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38784455
8.
ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia.
Biomed Pharmacother
; 150: 112962, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462331
9.
Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors.
Cancers (Basel)
; 12(6)2020 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32560251
10.
Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters.
Biochem Pharmacol
; 163: 290-298, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826329
11.
Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro.
Biochem Pharmacol
; 154: 10-17, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29673999
12.
In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
Med Chem
; 14(3): 281-292, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29332594
Resultados
1 -
12
de 12
1
Próxima >
>>